FDA Approves First CAR-T Therapy for Relapsed, Refractory Marginal Zone Lymphoma Dr. Kamal Kant Kohli5 Dec 2025 8:30 PM ISTThe U.S. Food and Drug Administration has approved a new indication for Breyanzi (Lisocabtagene maraleucel) as the first Chimeric Antigen Receptor...
Mesh Use Reduces Long-Term Reoperation After Emergent Ventral Hernia Repair: JAMA Medha Baranwal5 Dec 2025 8:30 PM ISTUSA: Researchers have found in a new study that the use of mesh during emergent open ventral hernia repair was linked to fewer long-term reoperations...
How Hydralazine Inhibits Growth of Glioblastoma, Study Sheds Light Medha Baranwal4 Dec 2025 8:45 PM ISTUSA: Researchers at the University of Pennsylvania have uncovered how hydralazine works and found that it may also inhibit the growth of glioblastoma,...
USC study suggests type 1 diabetes may significantly raise bladder cancer risk Dr. Kamal Kant Kohli4 Dec 2025 11:30 AM ISTPeople with type 1 diabetes (previously called juvenile diabetes) are 4.29 times more likely to develop bladder cancer, according to a systematic...
FDA Approves new Blood Test for detection of High-Grade Prostate Cancer Dr. Kamal Kant Kohli2 Dec 2025 8:30 PM ISTThe FDA has approved Cleveland Diagnostics' IsoPSA, a blood-based test designed to help identify high-grade prostate tumors and guide biopsy...
Bayer begins Phase III study with Mirena for nonatypical endometrial hyperplasia Ruchika Sharma2 Dec 2025 10:30 AM ISTBerlin: Bayer has announced the clinical Phase III study SUNFLOWER with its 52mg levonorgestrel-releasing intrauterine system (LNG-IUS) Mirena....
Proton Pump Inhibitors Linked to Worse Survival in Newly Diagnosed Glioblastoma: Study Jacinthlyn Sylvia1 Dec 2025 8:45 PM ISTA new study published in the Journal of American Medical Association showed that in patients with newly diagnosed glioblastoma, proton pump inhibitors...
Lupin secures USFDA nod for biosimilar Armlupeg Ruchika Sharma1 Dec 2025 10:48 AM ISTMumbai: Global pharma major Lupin Limited has announced that the United States Food and Drug Administration (U.S. FDA) has approved Armlupeg...
Targeted Chronic Myeloid Leukemia Drugs Show Divergent Cardiovascular Risk Profiles, JACC Cardio-Oncology State-of-the-Art Review Reports Dr. Bhumika Maikhuri1 Dec 2025 10:45 AM ISTA recent state-of-the-art review highlights that Cardiovascular disease (CVD) and CV risk factors are frequent in patients with Chronic Myeloid...
New Study: hs-TnT Levels Accurately Flag Cancer Patients at Risk of Serious Immunotherapy-Related Heart Events Medha Baranwal1 Dec 2025 9:00 AM ISTUSA: A new study published in the Journal of the American Heart Association has shed important light on the diagnostic and prognostic value of...
Mild Pancreatic Duct Dilatation Linked to Pancreatic Cancer Risk: Study Medha Baranwal30 Nov 2025 8:45 PM ISTUSA: A prospective cohort study published in Gastro Hep Advances has revealed that even mild dilatation of the main pancreatic duct (MPD)...
Proton Pump Inhibitors Linked to Worse Outcomes in Breast Cancer Patients: Study Dr Riya Dave28 Nov 2025 9:00 PM ISTResearchers have found in an observational study that breast cancer patients using proton pump inhibitors (PPIs) alongside anti-cancer therapies had...
